Terbutaline IV Push use with SubQ only Labeling

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

1 post / 0 new
Log in or register to post comments
Wed, 05/01/2024 - 13:16
#1
Megan Elizabeth...
Megan Elizabeth Fragale's picture
Offline
Last seen: 2 weeks 1 day ago
Joined: 02/14/2022 - 12:55
Terbutaline IV Push use with SubQ only Labeling

Hello colleagues,

With drugs like terbutaline, labeled for subcutaneous use only but used intravenously in practice, how do you address safe use with providers and nurses? A review of appropriate use of inactive ingredients makes sense as well as sharing literature support. Any thoughts/wisdom would be appreciated,

Megan Fragale, PharmD, MS, BCPS
Medication Safety Officer
Skagit Regional Health

Top